Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Regeneron backs $75M series A for antibody upstart Infinimmune

Regeneron backs $75M series A for antibody upstart Infinimmune

August 10, 2026Posted inBiotechnology

Infinimmune has amassed further fuel to power its antibody discovery engine, netting a $75 million series A headlined by Regeneron’s venture arm.

Post navigation

Previous Post
basemap-abe-launched-for-off-target-characterization-in-base-editing-therapeutic-development BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development
Next Post
Candida auris Persists in Hair Follicles, Hijacks Immune Signaling

Recent Posts

  • Observational study links GLP-1 initiation to more ankylosing spondylitis diagnoses
  • PSMA PET reveals uneven prostate-bed recurrence after prostatectomy
  • Portuguese breast cancer study validates trauma symptom scale, finds mixed growth-scale validity
  • UAV 3D canopy models estimate strawberry dry biomass in Florida field trial
  • 2022 Cross-Sectional Study Links Multisetting Generalist Groups to Lower Medicare MIPS Scores

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top